# Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)

> **NCT05226286** · NA · COMPLETED · sponsor: **MedtronicNeuro** · enrollment: 188 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DEVICE:** Medtronic Implantable Tibial Neuromodulation (TNM) System

## Key facts

- **NCT ID:** NCT05226286
- **Lead sponsor:** MedtronicNeuro
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-31
- **Primary completion:** 2023-10-10
- **Final completion:** 2025-05-30
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05226286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05226286, "Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05226286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*